Trial Profile
K-115 phase 2 dose-respopnse study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Ripasudil (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kowa
- 06 Nov 2015 New trial record